Clinical Trial Update: Efficacy and Tolerability of Full Dose Enteric-coated Mycophenolate Sodium, in Addition to Cyclosporine for Microemulsion Reduced Dose, in Maintenance Renal Transplant Recipients [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the addition of full-dose enteric-coated mycophenolate sodium to a reduced-dose cyclosporine regimen in maintenance renal transplant …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Mycophenolate sodium (Myfortic) (mycophenolate sodium)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Kidney Transplantation | Phase 4 | Status: TERMINATED | Results posted: 2011-04-07